Skip to main content

Market access for medical technologies in Slovenia

A brief overview of key market access pathways and challenges for medical devices, in-vitro diagnostic tests in Slovenia


Key topics

There is only one key theme describing market access for medical technologies in Slovenia: 

  • Reimbursement: payment mechanism via the DRG-adjusted budget system, List of separately billed materials


Hospital care is financed via a budget adjusted for activity based on DRGs. 

DRGs are determined by the combination of a procedure code (List of therapeutic and diagnostic procedures, an adjustment of the Australian ACHI classification) and a diagnosis code (ICD-10-AM). The procedure coding list and the DRG system are maintained by the Slovenian Health Insurance Fund (ZZZS).

The possibilities for establishing new codes and DRGs are limited on the national level, as the system is simply adopted from Australia (approximately every 10 years; translated into Slovenian and maintained by the National Institute of Public Health, NIJZ). DRG cost weights are updated annually and are published in the “General Agreement” by the Slovenian Health Insurance Fund. 

Certain materials are paid for separately, outside of the DRG system. These materials are present in the List of separately billed materials, LZM.


Specifics for IVD tests

In-vitro diagnostic tests provided in ambulatory settings are reimbursed on a fee-for-service basis via the List of laboratory tests, as present in the “General Agreement”.

How can MTRC help?

Development of reimbursement analysis (procedure coding, payment mechanism, reimbursement tariffs, policy and HTA considerations)

Development of reimbursement strategy 

Get in touch

Contact us to discuss your needs and learn about our services